Eagles drummer and singer Don Henley has a world of trouble on his mind, and he hopes that Congress will lighten his load... by gutting the best part of the Digital Millennium Copyright Act (DMCA). Defending his copyrights in the digital age is just too hard for Henley and his labels, because it requires constant vigilance of both mainstream user-upload sites like YouTube and dodgier destinations like BitTorrent trackers.

The European Union's Commissioner for Customs and Anti-Fraud is in China to discuss how the Chinese authorities and the E.U. can reduce trafficking in illegal products, particularly those that breach intellectual property rights by infringing on patents, copyrights or trademarks.

SCOTTSDALE, AZ -- (Marketwire) -- 08/31/10 -- TASER International, Inc. (NASDAQ: TASR), today announced that on August 30, 2010, the United States District Court for the District of Arizona entered judgment in favor of TASER International, Inc. ("TASER") against Stinger Systems, Inc. ("Stinger") on Count One of TASER's complaint and further ordered that "Stinger is hereby adjudged to have infringed claims 2 and 40 of United States Patent No. 6,999,295 ('the '295 patent')" and that "Claims 2 and 40 of the '295 patent are hereby adjudged to be valid and enforceable."

Sportswear manufacturer Nike has applied for a patent for a pair of automatically lacing trainers.

A patent dispute between chip designer CSR and US rival Broadcom seems to have escalated.

Apple's continuing in its efforts to dictate exactly what its products are used for by applying for a patent on a way to prevent iPhone and iPod users from jailbreaking their devices.

GOLDEN VALLEY, MN -- (Marketwire) -- 08/23/10 -- Veritec, Inc. (PINKSHEETS: VRTC) today announced that it has been awarded two patents from the United States and one patent from Vietnam. These patents address the need for data storage security and user friendly financial card security.

Taligen Therapeutics, a biotechnology company developing therapies that regulate
the complement system to treat inflammatory and immune diseases, announced today
that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,759,304,
entitled "Targeting Complement Factor H For Treatment of Diseases", covering the
composition of matter for its lead product candidate, TT30, a novel fusion
protein that selectively binds to complement activated cells to locally regulate
the complement system, as well as other complement receptor 2-Factor H (CR2-FH)
fusion compounds.

iCentera, the sales enablement company, today announced it has been awarded a patent (U.S. Pat. No. 7,774,378) for an invention that is central to delivering a hosted/SaaS-based sales enablement platform. When added to the roster of other iCentera sales enablement industry "firsts," the patent further solidifies iCentera's position as a pioneer and industry leader in one of today's hottest emerging software sectors. This patent corresponds to foundational aspects of the sales enablement intelligence center needed to deliver an enterprise-class sales enablement solution that can be deployed by virtually any B2B sales organization.

PROVIDENCIALES, Turks and Caicos, Aug. 13 /PRNewswire-FirstCall/ --
South Shore Resources Inc. (Pink Sheets: SSHO) (Frankfurt: SXB) (WKN:
A0LD9H) wishes to announce that it has received a letter of intent (LOI)
pursuant to which a private Ontario company headed by Mr. Erich Genseberger
wishes to purchase for $44 million, an exclusive 20 year license for use of
our intellectual (Hydrogen on Demand) property.